Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

被引:235
作者
Tunney, Michael M. [1 ,2 ]
Einarsson, Gisli G. [1 ,2 ]
Wei, Lan [1 ,2 ]
Drain, Maire [3 ]
Klem, Erich R. [4 ]
Cardwell, Chris [5 ]
Ennis, Madeleine [3 ]
Boucher, Richard C. [4 ]
Wolfgang, Matthew C. [4 ,6 ]
Elborn, J. Stuart [1 ,3 ]
机构
[1] Queens Univ Belfast, Cyst Fibrosis & Airways Microbiol Res Grp, Belfast BT9 7BL, Antrim, North Ireland
[2] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland
[3] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast BT9 7BL, Antrim, North Ireland
[4] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA
[5] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast BT9 7BL, Antrim, North Ireland
[6] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
bronchiectasis; lung microbiome; exacerbation; bacteria; CYSTIC FIBROSIS BRONCHIECTASIS; NON-CF BRONCHIECTASIS; QUALITY-OF-LIFE; PSEUDOMONAS-AERUGINOSA; INHALED TOBRAMYCIN; AIRWAY; SPUTUM; COMMUNITIES; DIVERSITY; AZITHROMYCIN;
D O I
10.1164/rccm.201210-1937OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Characterization of bacterial populations in infectious respiratory diseases will provide improved understanding of the relationship between the lung microbiota, disease pathogenesis, and treatment outcomes. Objectives: To comprehensively define lung microbiota composition during stable disease and exacerbation in patients with bronchiectasis. Methods: Sputum was collected from patients when clinically stable and before and after completion of antibiotic treatment of exacer-bations. Bacterial abundance and community composition were analyzed using anaerobic culture and 16S rDNA pyrosequencing. Measurements and Main Results: In clinically stable patients, aerobic and anaerobic bacteria were detected in 40 of 40 (100%) and 33 of 40 (83%) sputum samples, respectively. The dominant organisms cultured were Pseudomonas aeruginosa (n = 10 patients), Haemophilus influenzae (n = 12), Prevotella (n = 18), and Veillonella (n = 13). Pyrosequencing generated more than 150,000 sequences, representing 113 distinct microbial taxa; the majority of observed community richness resulted from taxa present in low abundance with similar patterns of phyla distribution in clinically stable patients and patients at the onset of exacerbation. After treatment of exacerbation, there was no change in total (P = 0.925), aerobic (P = 0.917), or anaerobic (P = 0.683) load and only a limited shift in community composition. Agreement for detection of bacteria by culture and pyrosequencing was good for aerobic bacteria such as P. aeruginosa (kappa = 0.84) but poorer for other genera including anaerobes. Lack of agreement was largely due to bacteria being detected by pyrosequencing but not by culture. Conclusions: A complex microbiota is present in the lungs of patients with bronchiectasis and remains stable through treatment of exacerbations, suggesting that changes in microbiota composition do not account for exacerbations.
引用
收藏
页码:1118 / 1126
页数:9
相关论文
共 61 条
[1]   Bacterial colonisation in patients with bronchiectasis:: microbiological pattern and risk factors [J].
Angrill, J ;
Agustí, C ;
de Celis, R ;
Rañó, A ;
Gonzalez, J ;
Solé, T ;
Xaubet, A ;
Rodriguez-Roisin, R ;
Torres, A .
THORAX, 2002, 57 (01) :15-19
[2]  
[Anonymous], GLOB STRAT DIAGN MAN
[3]   Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis [J].
Anwar, G. A. ;
Bourke, S. C. ;
Afolabi, G. ;
Middleton, P. ;
Ward, C. ;
Rutherford, R. M. .
RESPIRATORY MEDICINE, 2008, 102 (10) :1494-1496
[4]   Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis [J].
Barker, AF ;
Couch, L ;
Fiel, SB ;
Gotfried, MH ;
Ilowite, J ;
Meyer, KC ;
O'Donnell, A ;
Sahn, SA ;
Smith, LJ ;
Stewart, JO ;
Abuan, T ;
Tully, H ;
Van Dalfsen, J ;
Wells, CD ;
Quan, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) :481-485
[5]   Medical progress - Bronchiectasis [J].
Barker, AF .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (18) :1383-1393
[6]   Quantitative Analysis of the Human Airway Microbial Ecology Reveals a Pervasive Signature for Cystic Fibrosis [J].
Blainey, Paul C. ;
Milla, Carlos E. ;
Cornfield, David N. ;
Quake, Stephen R. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (153)
[7]   Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non-Cystic Fibrosis Bronchiectasis [J].
Chalmers, James D. ;
Smith, Maeve P. ;
McHugh, Brian J. ;
Doherty, Cathy ;
Govan, John R. ;
Hill, Adam T. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 186 (07) :657-665
[8]   Topographical Continuity of Bacterial Populations in the Healthy Human Respiratory Tract [J].
Charlson, Emily S. ;
Bittinger, Kyle ;
Haas, Andrew R. ;
Fitzgerald, Ayannah S. ;
Frank, Ian ;
Yadav, Anjana ;
Bushman, Frederic D. ;
Collman, Ronald G. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (08) :957-963
[9]   Effect of Estrogen on Pseudomonas Mucoidy and Exacerbations in Cystic Fibrosis [J].
Chotirmall, Sanjay H. ;
Smith, Stephen G. ;
Gunaratnam, Cedric ;
Cosgrove, Sonya ;
Dimitrov, Borislav D. ;
O'Neill, Shane J. ;
Harvey, Brian J. ;
Greene, Catherine M. ;
McElvaney, Noel G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21) :1978-1986
[10]  
Cox MB, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012132, 10.1371/journal.pone.0011044]